Metabolic Profile Elucidation of Ventilago calyculata Aqueous Extract Attenuating Sequelae of Aspirin Retarded Wound Healing
Shweta Kumar2, Rajesh Singh Pawar2,3★, Deepti Jain4★ Corresponding author
- 1Department of Pharmacy, Pharmacognosy and Pharmacology Laboratory, Faculty of Pharmacy, VNS Group of Institution, India.
- 2Department of Pharmacy, Truba Institute of Pharmacy, India.
- 3Department of Pharmacy, School of Pharmaceutical Sciences, RGPV, Bhopal, Madhya Pradesh, India.
CORRESPONDENCE
Rajesh Singh Pawar
Department of Pharmacy, Truba Institute of Pharmacy, India.
Received: 24-03-2019; Revised: 13-05-2019.
Volume 15, Issue 66s · pp. S426–S432 · PUBLISHED 28 November 2019 · DOI: 10.4103/pm.pm_131_19
View on Pharmacogn. Mag. original site ↗
ABSTRACT
Objective: The objective of this work was to test the potential of formulations prepared from the extracts of V. calyculata against aspirin‑retarded wound healing in rats and investigate the probable mechanism of action. Materials and Methods: The effect of topical administration of fractionates of V. calyculata against aspirin‑delayed wound healing was assessed in Wistar albino rats. The chemo‑profiling (liquid chromatography‑mass spectroscopy [LC‑MS]) of the extract with the most potent wound healing activity was carried out. Further, the mechanism of the most potent Ventilago calyculata aqueous extract (VCA) was determined by viability and plasma membrane integrity assays in H2O2‑challenged wild type Saccharomyces cerevisiae BY4743) and knock‑out strain (Δtrx2) strains. Results: The results of our investigations showed that in excision wound model; all formulations had statistically significant (P < 0.01) wound healing activity compared to the negative control. However, aqueous extract treatment (HF3) exhibited maximum activity, and the chemo‑profiling of VCA by LCMS suggested that the potent activity may be due to individual and/or synergistic effect of the identified pharmacologically active phytoconstituents. The study on yeast indicates that VCA was able to act intracellularly also as it was able to overcome the growth inhibitory effect of the H2O2 significantly (P < 0.01). Conclusion: We propose that treatment with HF3 (VCA) is a therapeutically beneficial method of decelerating wound retardation caused by aspirin intake in patients on long‑term aspirin therapy.
KEYWORDS
REFERENCES
As publishedShowing references and in-text citations exactly as published.
Cite this article
SELECT FORMAT
Kumar, S., Pawar, R. S., & Jain, D. (2019). Metabolic Profile Elucidation of Ventilago calyculata Aqueous Extract Attenuating Sequelae of Aspirin Retarded Wound Healing. Pharmacognosy Magazine, 15(66s), S426–S432. https://doi.org/10.4103/pm.pm_131_19